| http://www.w3.org/ns/prov#value | - and treatment of tumorEP2042517A1Sep 26, 2003Apr 1, 2009Xencor, Inc.Optimized FC variants and methods for their generationEP2050335A1Feb 9, 2007Apr 22, 2009Genentech, Inc.Gene disruptions, compositions and methods relating theretoEP2052742A1Jun 14, 2001Apr 29, 2009Biogen Idec Inc.Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/r
|
